the company was valued at $1.50 a share last year by Pitt Street, that was before the slew of news that the market has now got their hands on. Yes that is one analyst, and their value was pegged on acquisition value, but there is plenty of value for essentially first mover status and a moat. I do agree with your sentiment though, and we wont just be green day in day out for sure.
- Forums
- ASX - By Stock
- BRN
- 2022 BRN Discussion
2022 BRN Discussion, page-1758
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $522.7M |
Open | High | Low | Value | Volume |
26.5¢ | 27.0¢ | 26.0¢ | $2.161M | 8.144M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 431626 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 399533 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 246229 | 0.265 |
37 | 937177 | 0.260 |
20 | 689317 | 0.255 |
60 | 1236850 | 0.250 |
15 | 380331 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 350031 | 9 |
0.275 | 849419 | 17 |
0.280 | 823284 | 17 |
0.285 | 865045 | 23 |
0.290 | 1037484 | 19 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online